Advertisement
Advertisement
CCCC
C4 Therapeutics, Inc.
3.08
USDSponsored
-0.23
-6.95%
Sep 23, 15:59 UTC -4
Closed
After-Market
3.07
-0.01
-0.26%
C4 Therapeutics, Inc. Financial Snapshot
| Market Cap | 377.93M |
| Beta | 2.94 |
| Earnings Per Share (EPS) | -1.00 |
| Price-to-Book (P/B) Ratio | 1.48 |
| Operating Margin | -289.44% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -45.45% |
| Current Ratio | 5.45% |
| Free Cash Flow | -31.62M |
